UK NHS approves Wegovy oral pill for obesity treatment by 2028

The NHS is under pressure to expand access to weight-loss medications. The proven efficacy of semaglutide and the availability of an oral formulation will accelerate NHS approval for broader patient eligibility.

regulatory · Prediction Market

Implied probability (Yes)

72%

Closes

2028-07-06

More regulatory markets

• UK government increases teacher pay offer by 2%+ in 2027 — 45% Yes
• FIFA issues formal disciplinary action against Trump by 2026-12-31 — 70% Yes
• UK government to allocate £200M for river clean-up by 2026 — 70% Yes
• FIFA issues formal reprimand against U.S. Soccer for Trump interference — 75% Yes
• Trump administration implements AI guardrails by Q4 2026 — 70% Yes
• FIFA reinstates Balogun suspension within 30 days — 70% Yes
• Mississippi will revoke xAI's turbine loophole by Q4 2026 — 75% Yes
• Forge Global secures Anthropic approval within 6 months — 75% Yes

Browse all regulatory markets →